Pharmaceutical Technology - April 2024

Pharmaceutical Technology - April 2024

Issue link: https://www.e-digitaleditions.com/i/1519174

Contents of this Issue

Navigation

Page 1 of 18

mRNA VACCINE THERAPEUTICS PROVEN EXPERTISE Your partner for regulatory-driven, phase-appropriate analytical programs tailored to your product. We offer Total Quality Assurance expertise, helping you to navigate the challenges of development, regulatory submission, and production. cGMP | GLP | GCP LABORATORIES mRNA | OLIGOS | PEPTIDES | BIOLOGICS | VACCINES • Integrity • Identity and Sequence • Potency Assays • Capping Efficiency and Poly(A) Tail Characterisation • Specific Impurities • Advanced Delivery Technologies +44 (0)116 296 1620 intertek.com/pharmaceutical oligos@intertek.com 3rd ANNUAL INHALED & NASAL BIOLOGICS/DNA FORUM 2024 26-27 SEPT | CAMBRIDGE, UK Join us for a ground-breaking and insightful forum on inhaled and nasal biologics development. Don't miss the opportunity to hear from world-renowned industry leaders sharing the latest learnings on inhaled & nasal biologics and DNA medicine development, including our keynote speaker, Dr Jenny Lam, Associate Professor in Pharmaceutics at the UCL School of Pharmacy, UK. Find out more online→

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - April 2024 - Pharmaceutical Technology - April 2024